Researchers at IDIBAPS- Hospital Clínic have developed and validated a new CAR-T therapy called ARI0003 at a preclinical level. The new therapy combi1
The objective is to deepen the molecular and genomic understanding of various diseases and facilitate patient translation. The program has been funde1
A study led by researchers from the Clínic-IDIBAPS paves the way for the design and optimization of CAR T-cell therapy for greater effectiveness in t1
The goal of the KAIROS project, driven by 6 Clínic-IDIBAPS research groups, will be to enhance molecular and genetic knowledge about various diseases1
The IDIBAPS Board of Governors has approved the creation of a new research group. The decision follows the scientific evaluation of the researchers –1
The researchers’ goal is to develop a method to reverse the exhaustion that affects T-cells during protracted battles with tumor cells, preventing th1
